William Grady
Fred Hutchinson Cancer Research Center
Appearances
DateMay 9, 2023Talks on the blood based screening test clinical trial results that will occur in 2022 and 2023 (ECLIPSE, PREEMPT, BLUE-C) and effects on clinical care; updates on multi-cancer early detection test; emerging screening tests (Oncoguard, Colonosight, etc)…Presenter
Fred Hutchinson Cancer Research Center- DateMay 9, 2023Talks on the blood based screening test clinical trial results that will occur in 2022 and 2023 (ECLIPSE, PREEMPT, BLUE-C) and effects on clinical care; updates on multi-cancer early detection test; emerging screening tests (Oncoguard, Colonosight, etc)…
Presenters
Fred Hutchinson Cancer Research CenterUniversity of Michigan 
DateMay 9, 2023SOCIETY: AGAModerators
Mayo ClinicFred Hutchinson Cancer Research Center- DateMay 9, 2023BACKGROUND: Gut dysbiosis is associated with persistent multi-system symptoms following SARS-CoV-2 infection, or post-acute COVID-19 syndrome (PACS). We performed a randomised controlled trial to assess the effects of gut microbiome modulation on alleviation of PACS symptoms…
Presenter
Speakers
University of California San DiegoFred Hutchinson Cancer CenterFred Hutchinson Cancer Research Center - DateMay 18, 2024
Presenter
Fred Hutchinson Cancer Research Center - DateMay 21, 2024
Presenter
Fred Hutchinson Cancer Research Center - DateMay 21, 2024
Presenters
- DateMay 20, 2024
Presenter
Fred Hutchinson Cancer Research Center 
DateMay 18, 2024SOCIETY: AGA Advances in technology and our understanding of pathogenesis of GI malignancies are leading to innovations in screening and surveillance strategies. In this session we will learn about emerging technologies for BE screening and risk stratification…Moderators
Oregon Health and Science UniversityUniversity of KansasSpeakers
